Antihypertensive Treatment in Masked Hypertension for Target Organ Protection(ANTI-MASK)
Latest Information Update: 07 Sep 2023
At a glance
- Drugs Allisartan (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms ANTI-MASK
- 20 Jun 2022 Primary endpoint Improvement rate of target organ damage (left ventricular hypertrophy, large arterial stiffness and microalbuminuria)) has been met as per results presented at the 31st European meeting on hypertension and cardiovascular protection
- 20 Jun 2022 Results presented at the 31st European meeting on hypertension and cardiovascular protection
- 27 Sep 2021 Planned End Date changed from 31 Dec 2021 to 30 Oct 2021.